Global Antimicrobial Susceptibility Testing Products Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Antimicrobial Susceptibility Testing Products market size was valued at US$ 4424 million in 2025 and is forecast to a readjusted size of US$ 6444 million by 2032 with a CAGR of 5.5% during review period.
Antimicrobial Susceptibility Testing Products are a group of diagnostic and laboratory products used to evaluate, under in vitro conditions, how bacteria, yeasts, and certain other microorganisms respond to antimicrobial agents, and to generate categorical susceptible/intermediate/resistant results or quantitative minimum inhibitory concentration outputs. In commercial form, they include benchtop or floor-standing automated AST analyzers, integrated ID/AST systems, rapid phenotypic AST instruments, as well as AST cards, panels, microplates, susceptibility discs, gradient diffusion strips, Mueller-Hinton agar and broth media, together with dispensers, reading modules, software, and quality-control accessories. Their technical basis mainly relies on disk diffusion, broth microdilution, agar dilution, gradient diffusion, and newer rapid phenotypic imaging or microfluidic approaches that determine whether microbial growth is inhibited at defined antimicrobial concentrations. Commercial supply is provided by clinical microbiology IVD manufacturers, culture media and AST consumables producers, laboratory automation companies, and rapid AST innovators. These products are primarily used in hospital microbiology laboratories, independent clinical labs, public-health and reference laboratories, veterinary diagnostics, pharmaceutical R&D, and selected food, agriculture, and environmental microbiology settings.
The global antimicrobial resistance burden continues to reinforce the structural demand for Antimicrobial Susceptibility Testing Products. Hospitals are under increasing pressure to provide effective therapy recommendations earlier, shorten empirical broad-spectrum antibiotic exposure, and support antimicrobial stewardship programs, which is driving laboratories to upgrade from traditional manual testing toward more automated, standardized, and faster-turnaround solutions. Bloodstream infection, sepsis, intensive care, and other high-resistance settings are the most time-sensitive use cases, making rapid phenotypic AST technologies that work directly from positive blood cultures or within shorter incubation workflows a major growth opportunity. At the same time, the launch of new antimicrobials and combination therapies requires constant updates of AST panels, breakpoint databases, expert rules, and interpretation software, favoring suppliers that can offer integrated instrument, consumable, software, and rule-engine capabilities.
The main market constraints come from methodology, regulation, and commercialization. AST results must remain aligned with CLSI, EUCAST, and national regulatory requirements, while breakpoint changes, new resistance mechanisms, and limited coverage for rare organisms raise validation and maintenance costs. Rapid AST has clear clinical value, but real-world purchasing is still constrained by budgets, installed-base economics, laboratory workflow redesign, LIS connectivity, quality-control complexity, and local registration timing. For many small and mid-sized laboratories, conventional discs, microdilution panels, and semi-automated systems still hold an obvious cost advantage, so penetration of high-end rapid AST platforms is unlikely to occur in a single step. In addition, regulatory boundaries between clinical, veterinary, research, and industrial use differ across countries, increasing the burden of multi-region registration, comparative studies, and supply-chain localization for global expansion.
Downstream demand is evolving along two main paths. The first is the clinical shift from merely performing AST to delivering results faster, in a more standardized way, and with better workflow integration; this is increasing demand for integrated ID/AST systems, rapid AST platforms linked to blood-culture workflows, automated reading and middleware, standardized media, and quality-control consumables. The second is boundary expansion beyond human clinical diagnostics. Veterinary diagnostics, public-health surveillance, resistance epidemiology, antimicrobial drug development, and selected food and agricultural microbiology applications are all increasing their use of quantitative and traceable AST tools. The future market is therefore unlikely to be driven by a single analyzer alone; instead, it is moving toward a composite revenue model built around instruments, cards/panels/strips/discs, media, software databases, and ongoing rule-update services, with consumables and interpretation maintenance continuing to gain value.
This report is a detailed and comprehensive analysis for global Antimicrobial Susceptibility Testing Products market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Antimicrobial Susceptibility Testing Products market size and forecasts, in consumption value ($ Million), 2021-2032
Global Antimicrobial Susceptibility Testing Products market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Antimicrobial Susceptibility Testing Products market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Antimicrobial Susceptibility Testing Products market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Antimicrobial Susceptibility Testing Products market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Antimicrobial Susceptibility Testing Products are a group of diagnostic and laboratory products used to evaluate, under in vitro conditions, how bacteria, yeasts, and certain other microorganisms respond to antimicrobial agents, and to generate categorical susceptible/intermediate/resistant results or quantitative minimum inhibitory concentration outputs. In commercial form, they include benchtop or floor-standing automated AST analyzers, integrated ID/AST systems, rapid phenotypic AST instruments, as well as AST cards, panels, microplates, susceptibility discs, gradient diffusion strips, Mueller-Hinton agar and broth media, together with dispensers, reading modules, software, and quality-control accessories. Their technical basis mainly relies on disk diffusion, broth microdilution, agar dilution, gradient diffusion, and newer rapid phenotypic imaging or microfluidic approaches that determine whether microbial growth is inhibited at defined antimicrobial concentrations. Commercial supply is provided by clinical microbiology IVD manufacturers, culture media and AST consumables producers, laboratory automation companies, and rapid AST innovators. These products are primarily used in hospital microbiology laboratories, independent clinical labs, public-health and reference laboratories, veterinary diagnostics, pharmaceutical R&D, and selected food, agriculture, and environmental microbiology settings.
The global antimicrobial resistance burden continues to reinforce the structural demand for Antimicrobial Susceptibility Testing Products. Hospitals are under increasing pressure to provide effective therapy recommendations earlier, shorten empirical broad-spectrum antibiotic exposure, and support antimicrobial stewardship programs, which is driving laboratories to upgrade from traditional manual testing toward more automated, standardized, and faster-turnaround solutions. Bloodstream infection, sepsis, intensive care, and other high-resistance settings are the most time-sensitive use cases, making rapid phenotypic AST technologies that work directly from positive blood cultures or within shorter incubation workflows a major growth opportunity. At the same time, the launch of new antimicrobials and combination therapies requires constant updates of AST panels, breakpoint databases, expert rules, and interpretation software, favoring suppliers that can offer integrated instrument, consumable, software, and rule-engine capabilities.
The main market constraints come from methodology, regulation, and commercialization. AST results must remain aligned with CLSI, EUCAST, and national regulatory requirements, while breakpoint changes, new resistance mechanisms, and limited coverage for rare organisms raise validation and maintenance costs. Rapid AST has clear clinical value, but real-world purchasing is still constrained by budgets, installed-base economics, laboratory workflow redesign, LIS connectivity, quality-control complexity, and local registration timing. For many small and mid-sized laboratories, conventional discs, microdilution panels, and semi-automated systems still hold an obvious cost advantage, so penetration of high-end rapid AST platforms is unlikely to occur in a single step. In addition, regulatory boundaries between clinical, veterinary, research, and industrial use differ across countries, increasing the burden of multi-region registration, comparative studies, and supply-chain localization for global expansion.
Downstream demand is evolving along two main paths. The first is the clinical shift from merely performing AST to delivering results faster, in a more standardized way, and with better workflow integration; this is increasing demand for integrated ID/AST systems, rapid AST platforms linked to blood-culture workflows, automated reading and middleware, standardized media, and quality-control consumables. The second is boundary expansion beyond human clinical diagnostics. Veterinary diagnostics, public-health surveillance, resistance epidemiology, antimicrobial drug development, and selected food and agricultural microbiology applications are all increasing their use of quantitative and traceable AST tools. The future market is therefore unlikely to be driven by a single analyzer alone; instead, it is moving toward a composite revenue model built around instruments, cards/panels/strips/discs, media, software databases, and ongoing rule-update services, with consumables and interpretation maintenance continuing to gain value.
This report is a detailed and comprehensive analysis for global Antimicrobial Susceptibility Testing Products market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Antimicrobial Susceptibility Testing Products market size and forecasts, in consumption value ($ Million), 2021-2032
Global Antimicrobial Susceptibility Testing Products market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Antimicrobial Susceptibility Testing Products market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Antimicrobial Susceptibility Testing Products market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Antimicrobial Susceptibility Testing Products
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Antimicrobial Susceptibility Testing Products market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- AST Instruments and Systems
- AST Test Consumables
- AST Media and Reagents
- AST Software and Data Tools
- Others
- Diffusion-based AST
- Dilution-based AST
- Growth Kinetics or Imaging-based AST
- Microfluidic Rapid Phenotypic AST
- Genotypic or Resistance-marker-guided Testing
- Others
- Manual AST Products
- Semi-automated AST Products
- Fully Automated AST Products
- Capital Equipment
- Single-use Test Consumables
- Media and Supporting Supplies
- Software, Database and Interpretation Tools
- Others
- Clinical Diagnostics
- Drug Discovery and Development
- Epidemiology
- Others
- Danaher
- Thermo Fisher Scientific
- BD
- bioM?rieux
- Merck
- Sysmex
- Mindray
- Bio-Rad
- Bruker
- Eiken Chemical
- Copan Diagnostics
- Q-linea
- QuantaMatrix
- HiMedia Laboratories
- Liofilchem
- Autobio Diagnostics
- Mast Group
- Erba Lachema
- Alifax
- ZHUHAI DL BIOTECH
- Kyokuto Pharmaceutical Industrial
- Condalab
- Titan Biotech
- Guangdong Huankai Microbial
- Bioanalyse
- Synbiosis
- Biolife Italiana
- Gradientech
- Selux Diagnostics
- iFAST Diagnostics
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
- Chapter 1, to describe Antimicrobial Susceptibility Testing Products product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top players of Antimicrobial Susceptibility Testing Products, with revenue, gross margin, and global market share of Antimicrobial Susceptibility Testing Products from 2021 to 2026.
- Chapter 3, the Antimicrobial Susceptibility Testing Products competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
- Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Antimicrobial Susceptibility Testing Products market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
- Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
- Chapter 12, the key raw materials and key suppliers, and industry chain of Antimicrobial Susceptibility Testing Products.
- Chapter 13, to describe Antimicrobial Susceptibility Testing Products research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Antimicrobial Susceptibility Testing Products by Type
1.3.1 Overview: Global Antimicrobial Susceptibility Testing Products Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Type in 2025
1.3.3 AST Instruments and Systems
1.3.4 AST Test Consumables
1.3.5 AST Media and Reagents
1.3.6 AST Software and Data Tools
1.3.7 Others
1.4 Classification of Antimicrobial Susceptibility Testing Products by Core Testing Principle
1.4.1 Overview: Global Antimicrobial Susceptibility Testing Products Market Size by Core Testing Principle: 2021 Versus 2025 Versus 2032
1.4.2 Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Core Testing Principle in 2025
1.4.3 Diffusion-based AST
1.4.4 Dilution-based AST
1.4.5 Growth Kinetics or Imaging-based AST
1.4.6 Microfluidic Rapid Phenotypic AST
1.4.7 Genotypic or Resistance-marker-guided Testing
1.4.8 Others
1.5 Classification of Antimicrobial Susceptibility Testing Products by Automation Level
1.5.1 Overview: Global Antimicrobial Susceptibility Testing Products Market Size by Automation Level: 2021 Versus 2025 Versus 2032
1.5.2 Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Automation Level in 2025
1.5.3 Manual AST Products
1.5.4 Semi-automated AST Products
1.5.5 Fully Automated AST Products
1.6 Classification of Antimicrobial Susceptibility Testing Products by Delivery Format
1.6.1 Overview: Global Antimicrobial Susceptibility Testing Products Market Size by Delivery Format: 2021 Versus 2025 Versus 2032
1.6.2 Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Delivery Format in 2025
1.6.3 Capital Equipment
1.6.4 Single-use Test Consumables
1.6.5 Media and Supporting Supplies
1.6.6 Software, Database and Interpretation Tools
1.6.7 Others
1.7 Global Antimicrobial Susceptibility Testing Products Market by Application
1.7.1 Overview: Global Antimicrobial Susceptibility Testing Products Market Size by Application: 2021 Versus 2025 Versus 2032
1.7.2 Clinical Diagnostics
1.7.3 Drug Discovery and Development
1.7.4 Epidemiology
1.7.5 Others
1.8 Global Antimicrobial Susceptibility Testing Products Market Size & Forecast
1.9 Global Antimicrobial Susceptibility Testing Products Market Size and Forecast by Region
1.9.1 Global Antimicrobial Susceptibility Testing Products Market Size by Region: 2021 VS 2025 VS 2032
1.9.2 Global Antimicrobial Susceptibility Testing Products Market Size by Region, (2021-2032)
1.9.3 North America Antimicrobial Susceptibility Testing Products Market Size and Prospect (2021-2032)
1.9.4 Europe Antimicrobial Susceptibility Testing Products Market Size and Prospect (2021-2032)
1.9.5 Asia-Pacific Antimicrobial Susceptibility Testing Products Market Size and Prospect (2021-2032)
1.9.6 South America Antimicrobial Susceptibility Testing Products Market Size and Prospect (2021-2032)
1.9.7 Middle East & Africa Antimicrobial Susceptibility Testing Products Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Danaher
2.1.1 Danaher Details
2.1.2 Danaher Major Business
2.1.3 Danaher Antimicrobial Susceptibility Testing Products Product and Solutions
2.1.4 Danaher Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Danaher Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Antimicrobial Susceptibility Testing Products Product and Solutions
2.2.4 Thermo Fisher Scientific Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 BD
2.3.1 BD Details
2.3.2 BD Major Business
2.3.3 BD Antimicrobial Susceptibility Testing Products Product and Solutions
2.3.4 BD Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 BD Recent Developments and Future Plans
2.4 bioM?rieux
2.4.1 bioM?rieux Details
2.4.2 bioM?rieux Major Business
2.4.3 bioM?rieux Antimicrobial Susceptibility Testing Products Product and Solutions
2.4.4 bioM?rieux Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 bioM?rieux Recent Developments and Future Plans
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Antimicrobial Susceptibility Testing Products Product and Solutions
2.5.4 Merck Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Merck Recent Developments and Future Plans
2.6 Sysmex
2.6.1 Sysmex Details
2.6.2 Sysmex Major Business
2.6.3 Sysmex Antimicrobial Susceptibility Testing Products Product and Solutions
2.6.4 Sysmex Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Sysmex Recent Developments and Future Plans
2.7 Mindray
2.7.1 Mindray Details
2.7.2 Mindray Major Business
2.7.3 Mindray Antimicrobial Susceptibility Testing Products Product and Solutions
2.7.4 Mindray Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Mindray Recent Developments and Future Plans
2.8 Bio-Rad
2.8.1 Bio-Rad Details
2.8.2 Bio-Rad Major Business
2.8.3 Bio-Rad Antimicrobial Susceptibility Testing Products Product and Solutions
2.8.4 Bio-Rad Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Bio-Rad Recent Developments and Future Plans
2.9 Bruker
2.9.1 Bruker Details
2.9.2 Bruker Major Business
2.9.3 Bruker Antimicrobial Susceptibility Testing Products Product and Solutions
2.9.4 Bruker Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Bruker Recent Developments and Future Plans
2.10 Eiken Chemical
2.10.1 Eiken Chemical Details
2.10.2 Eiken Chemical Major Business
2.10.3 Eiken Chemical Antimicrobial Susceptibility Testing Products Product and Solutions
2.10.4 Eiken Chemical Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Eiken Chemical Recent Developments and Future Plans
2.11 Copan Diagnostics
2.11.1 Copan Diagnostics Details
2.11.2 Copan Diagnostics Major Business
2.11.3 Copan Diagnostics Antimicrobial Susceptibility Testing Products Product and Solutions
2.11.4 Copan Diagnostics Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Copan Diagnostics Recent Developments and Future Plans
2.12 Q-linea
2.12.1 Q-linea Details
2.12.2 Q-linea Major Business
2.12.3 Q-linea Antimicrobial Susceptibility Testing Products Product and Solutions
2.12.4 Q-linea Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Q-linea Recent Developments and Future Plans
2.13 QuantaMatrix
2.13.1 QuantaMatrix Details
2.13.2 QuantaMatrix Major Business
2.13.3 QuantaMatrix Antimicrobial Susceptibility Testing Products Product and Solutions
2.13.4 QuantaMatrix Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 QuantaMatrix Recent Developments and Future Plans
2.14 HiMedia Laboratories
2.14.1 HiMedia Laboratories Details
2.14.2 HiMedia Laboratories Major Business
2.14.3 HiMedia Laboratories Antimicrobial Susceptibility Testing Products Product and Solutions
2.14.4 HiMedia Laboratories Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 HiMedia Laboratories Recent Developments and Future Plans
2.15 Liofilchem
2.15.1 Liofilchem Details
2.15.2 Liofilchem Major Business
2.15.3 Liofilchem Antimicrobial Susceptibility Testing Products Product and Solutions
2.15.4 Liofilchem Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Liofilchem Recent Developments and Future Plans
2.16 Autobio Diagnostics
2.16.1 Autobio Diagnostics Details
2.16.2 Autobio Diagnostics Major Business
2.16.3 Autobio Diagnostics Antimicrobial Susceptibility Testing Products Product and Solutions
2.16.4 Autobio Diagnostics Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Autobio Diagnostics Recent Developments and Future Plans
2.17 Mast Group
2.17.1 Mast Group Details
2.17.2 Mast Group Major Business
2.17.3 Mast Group Antimicrobial Susceptibility Testing Products Product and Solutions
2.17.4 Mast Group Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Mast Group Recent Developments and Future Plans
2.18 Erba Lachema
2.18.1 Erba Lachema Details
2.18.2 Erba Lachema Major Business
2.18.3 Erba Lachema Antimicrobial Susceptibility Testing Products Product and Solutions
2.18.4 Erba Lachema Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Erba Lachema Recent Developments and Future Plans
2.19 Alifax
2.19.1 Alifax Details
2.19.2 Alifax Major Business
2.19.3 Alifax Antimicrobial Susceptibility Testing Products Product and Solutions
2.19.4 Alifax Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Alifax Recent Developments and Future Plans
2.20 ZHUHAI DL BIOTECH
2.20.1 ZHUHAI DL BIOTECH Details
2.20.2 ZHUHAI DL BIOTECH Major Business
2.20.3 ZHUHAI DL BIOTECH Antimicrobial Susceptibility Testing Products Product and Solutions
2.20.4 ZHUHAI DL BIOTECH Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 ZHUHAI DL BIOTECH Recent Developments and Future Plans
2.21 Kyokuto Pharmaceutical Industrial
2.21.1 Kyokuto Pharmaceutical Industrial Details
2.21.2 Kyokuto Pharmaceutical Industrial Major Business
2.21.3 Kyokuto Pharmaceutical Industrial Antimicrobial Susceptibility Testing Products Product and Solutions
2.21.4 Kyokuto Pharmaceutical Industrial Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Kyokuto Pharmaceutical Industrial Recent Developments and Future Plans
2.22 Condalab
2.22.1 Condalab Details
2.22.2 Condalab Major Business
2.22.3 Condalab Antimicrobial Susceptibility Testing Products Product and Solutions
2.22.4 Condalab Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 Condalab Recent Developments and Future Plans
2.23 Titan Biotech
2.23.1 Titan Biotech Details
2.23.2 Titan Biotech Major Business
2.23.3 Titan Biotech Antimicrobial Susceptibility Testing Products Product and Solutions
2.23.4 Titan Biotech Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Titan Biotech Recent Developments and Future Plans
2.24 Guangdong Huankai Microbial
2.24.1 Guangdong Huankai Microbial Details
2.24.2 Guangdong Huankai Microbial Major Business
2.24.3 Guangdong Huankai Microbial Antimicrobial Susceptibility Testing Products Product and Solutions
2.24.4 Guangdong Huankai Microbial Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Guangdong Huankai Microbial Recent Developments and Future Plans
2.25 Bioanalyse
2.25.1 Bioanalyse Details
2.25.2 Bioanalyse Major Business
2.25.3 Bioanalyse Antimicrobial Susceptibility Testing Products Product and Solutions
2.25.4 Bioanalyse Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 Bioanalyse Recent Developments and Future Plans
2.26 Synbiosis
2.26.1 Synbiosis Details
2.26.2 Synbiosis Major Business
2.26.3 Synbiosis Antimicrobial Susceptibility Testing Products Product and Solutions
2.26.4 Synbiosis Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 Synbiosis Recent Developments and Future Plans
2.27 Biolife Italiana
2.27.1 Biolife Italiana Details
2.27.2 Biolife Italiana Major Business
2.27.3 Biolife Italiana Antimicrobial Susceptibility Testing Products Product and Solutions
2.27.4 Biolife Italiana Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.27.5 Biolife Italiana Recent Developments and Future Plans
2.28 Gradientech
2.28.1 Gradientech Details
2.28.2 Gradientech Major Business
2.28.3 Gradientech Antimicrobial Susceptibility Testing Products Product and Solutions
2.28.4 Gradientech Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.28.5 Gradientech Recent Developments and Future Plans
2.29 Selux Diagnostics
2.29.1 Selux Diagnostics Details
2.29.2 Selux Diagnostics Major Business
2.29.3 Selux Diagnostics Antimicrobial Susceptibility Testing Products Product and Solutions
2.29.4 Selux Diagnostics Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.29.5 Selux Diagnostics Recent Developments and Future Plans
2.30 iFAST Diagnostics
2.30.1 iFAST Diagnostics Details
2.30.2 iFAST Diagnostics Major Business
2.30.3 iFAST Diagnostics Antimicrobial Susceptibility Testing Products Product and Solutions
2.30.4 iFAST Diagnostics Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.30.5 iFAST Diagnostics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Antimicrobial Susceptibility Testing Products Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Antimicrobial Susceptibility Testing Products by Company Revenue
3.2.2 Top 3 Antimicrobial Susceptibility Testing Products Players Market Share in 2025
3.2.3 Top 6 Antimicrobial Susceptibility Testing Products Players Market Share in 2025
3.3 Antimicrobial Susceptibility Testing Products Market: Overall Company Footprint Analysis
3.3.1 Antimicrobial Susceptibility Testing Products Market: Region Footprint
3.3.2 Antimicrobial Susceptibility Testing Products Market: Company Product Type Footprint
3.3.3 Antimicrobial Susceptibility Testing Products Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Antimicrobial Susceptibility Testing Products Consumption Value and Market Share by Type (2021-2026)
4.2 Global Antimicrobial Susceptibility Testing Products Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Application (2021-2026)
5.2 Global Antimicrobial Susceptibility Testing Products Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Antimicrobial Susceptibility Testing Products Consumption Value by Type (2021-2032)
6.2 North America Antimicrobial Susceptibility Testing Products Market Size by Application (2021-2032)
6.3 North America Antimicrobial Susceptibility Testing Products Market Size by Country
6.3.1 North America Antimicrobial Susceptibility Testing Products Consumption Value by Country (2021-2032)
6.3.2 United States Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
6.3.3 Canada Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
6.3.4 Mexico Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Antimicrobial Susceptibility Testing Products Consumption Value by Type (2021-2032)
7.2 Europe Antimicrobial Susceptibility Testing Products Consumption Value by Application (2021-2032)
7.3 Europe Antimicrobial Susceptibility Testing Products Market Size by Country
7.3.1 Europe Antimicrobial Susceptibility Testing Products Consumption Value by Country (2021-2032)
7.3.2 Germany Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
7.3.3 France Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
7.3.5 Russia Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
7.3.6 Italy Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Antimicrobial Susceptibility Testing Products Market Size by Region
8.3.1 Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value by Region (2021-2032)
8.3.2 China Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
8.3.3 Japan Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
8.3.4 South Korea Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
8.3.5 India Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
8.3.7 Australia Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Antimicrobial Susceptibility Testing Products Consumption Value by Type (2021-2032)
9.2 South America Antimicrobial Susceptibility Testing Products Consumption Value by Application (2021-2032)
9.3 South America Antimicrobial Susceptibility Testing Products Market Size by Country
9.3.1 South America Antimicrobial Susceptibility Testing Products Consumption Value by Country (2021-2032)
9.3.2 Brazil Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
9.3.3 Argentina Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Antimicrobial Susceptibility Testing Products Market Size by Country
10.3.1 Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value by Country (2021-2032)
10.3.2 Turkey Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
10.3.4 UAE Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Antimicrobial Susceptibility Testing Products Market Drivers
11.2 Antimicrobial Susceptibility Testing Products Market Restraints
11.3 Antimicrobial Susceptibility Testing Products Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Antimicrobial Susceptibility Testing Products Industry Chain
12.2 Antimicrobial Susceptibility Testing Products Upstream Analysis
12.3 Antimicrobial Susceptibility Testing Products Midstream Analysis
12.4 Antimicrobial Susceptibility Testing Products Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Antimicrobial Susceptibility Testing Products by Type
1.3.1 Overview: Global Antimicrobial Susceptibility Testing Products Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Type in 2025
1.3.3 AST Instruments and Systems
1.3.4 AST Test Consumables
1.3.5 AST Media and Reagents
1.3.6 AST Software and Data Tools
1.3.7 Others
1.4 Classification of Antimicrobial Susceptibility Testing Products by Core Testing Principle
1.4.1 Overview: Global Antimicrobial Susceptibility Testing Products Market Size by Core Testing Principle: 2021 Versus 2025 Versus 2032
1.4.2 Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Core Testing Principle in 2025
1.4.3 Diffusion-based AST
1.4.4 Dilution-based AST
1.4.5 Growth Kinetics or Imaging-based AST
1.4.6 Microfluidic Rapid Phenotypic AST
1.4.7 Genotypic or Resistance-marker-guided Testing
1.4.8 Others
1.5 Classification of Antimicrobial Susceptibility Testing Products by Automation Level
1.5.1 Overview: Global Antimicrobial Susceptibility Testing Products Market Size by Automation Level: 2021 Versus 2025 Versus 2032
1.5.2 Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Automation Level in 2025
1.5.3 Manual AST Products
1.5.4 Semi-automated AST Products
1.5.5 Fully Automated AST Products
1.6 Classification of Antimicrobial Susceptibility Testing Products by Delivery Format
1.6.1 Overview: Global Antimicrobial Susceptibility Testing Products Market Size by Delivery Format: 2021 Versus 2025 Versus 2032
1.6.2 Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Delivery Format in 2025
1.6.3 Capital Equipment
1.6.4 Single-use Test Consumables
1.6.5 Media and Supporting Supplies
1.6.6 Software, Database and Interpretation Tools
1.6.7 Others
1.7 Global Antimicrobial Susceptibility Testing Products Market by Application
1.7.1 Overview: Global Antimicrobial Susceptibility Testing Products Market Size by Application: 2021 Versus 2025 Versus 2032
1.7.2 Clinical Diagnostics
1.7.3 Drug Discovery and Development
1.7.4 Epidemiology
1.7.5 Others
1.8 Global Antimicrobial Susceptibility Testing Products Market Size & Forecast
1.9 Global Antimicrobial Susceptibility Testing Products Market Size and Forecast by Region
1.9.1 Global Antimicrobial Susceptibility Testing Products Market Size by Region: 2021 VS 2025 VS 2032
1.9.2 Global Antimicrobial Susceptibility Testing Products Market Size by Region, (2021-2032)
1.9.3 North America Antimicrobial Susceptibility Testing Products Market Size and Prospect (2021-2032)
1.9.4 Europe Antimicrobial Susceptibility Testing Products Market Size and Prospect (2021-2032)
1.9.5 Asia-Pacific Antimicrobial Susceptibility Testing Products Market Size and Prospect (2021-2032)
1.9.6 South America Antimicrobial Susceptibility Testing Products Market Size and Prospect (2021-2032)
1.9.7 Middle East & Africa Antimicrobial Susceptibility Testing Products Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Danaher
2.1.1 Danaher Details
2.1.2 Danaher Major Business
2.1.3 Danaher Antimicrobial Susceptibility Testing Products Product and Solutions
2.1.4 Danaher Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Danaher Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Antimicrobial Susceptibility Testing Products Product and Solutions
2.2.4 Thermo Fisher Scientific Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 BD
2.3.1 BD Details
2.3.2 BD Major Business
2.3.3 BD Antimicrobial Susceptibility Testing Products Product and Solutions
2.3.4 BD Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 BD Recent Developments and Future Plans
2.4 bioM?rieux
2.4.1 bioM?rieux Details
2.4.2 bioM?rieux Major Business
2.4.3 bioM?rieux Antimicrobial Susceptibility Testing Products Product and Solutions
2.4.4 bioM?rieux Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 bioM?rieux Recent Developments and Future Plans
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Antimicrobial Susceptibility Testing Products Product and Solutions
2.5.4 Merck Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Merck Recent Developments and Future Plans
2.6 Sysmex
2.6.1 Sysmex Details
2.6.2 Sysmex Major Business
2.6.3 Sysmex Antimicrobial Susceptibility Testing Products Product and Solutions
2.6.4 Sysmex Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Sysmex Recent Developments and Future Plans
2.7 Mindray
2.7.1 Mindray Details
2.7.2 Mindray Major Business
2.7.3 Mindray Antimicrobial Susceptibility Testing Products Product and Solutions
2.7.4 Mindray Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Mindray Recent Developments and Future Plans
2.8 Bio-Rad
2.8.1 Bio-Rad Details
2.8.2 Bio-Rad Major Business
2.8.3 Bio-Rad Antimicrobial Susceptibility Testing Products Product and Solutions
2.8.4 Bio-Rad Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Bio-Rad Recent Developments and Future Plans
2.9 Bruker
2.9.1 Bruker Details
2.9.2 Bruker Major Business
2.9.3 Bruker Antimicrobial Susceptibility Testing Products Product and Solutions
2.9.4 Bruker Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Bruker Recent Developments and Future Plans
2.10 Eiken Chemical
2.10.1 Eiken Chemical Details
2.10.2 Eiken Chemical Major Business
2.10.3 Eiken Chemical Antimicrobial Susceptibility Testing Products Product and Solutions
2.10.4 Eiken Chemical Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Eiken Chemical Recent Developments and Future Plans
2.11 Copan Diagnostics
2.11.1 Copan Diagnostics Details
2.11.2 Copan Diagnostics Major Business
2.11.3 Copan Diagnostics Antimicrobial Susceptibility Testing Products Product and Solutions
2.11.4 Copan Diagnostics Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Copan Diagnostics Recent Developments and Future Plans
2.12 Q-linea
2.12.1 Q-linea Details
2.12.2 Q-linea Major Business
2.12.3 Q-linea Antimicrobial Susceptibility Testing Products Product and Solutions
2.12.4 Q-linea Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Q-linea Recent Developments and Future Plans
2.13 QuantaMatrix
2.13.1 QuantaMatrix Details
2.13.2 QuantaMatrix Major Business
2.13.3 QuantaMatrix Antimicrobial Susceptibility Testing Products Product and Solutions
2.13.4 QuantaMatrix Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 QuantaMatrix Recent Developments and Future Plans
2.14 HiMedia Laboratories
2.14.1 HiMedia Laboratories Details
2.14.2 HiMedia Laboratories Major Business
2.14.3 HiMedia Laboratories Antimicrobial Susceptibility Testing Products Product and Solutions
2.14.4 HiMedia Laboratories Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 HiMedia Laboratories Recent Developments and Future Plans
2.15 Liofilchem
2.15.1 Liofilchem Details
2.15.2 Liofilchem Major Business
2.15.3 Liofilchem Antimicrobial Susceptibility Testing Products Product and Solutions
2.15.4 Liofilchem Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Liofilchem Recent Developments and Future Plans
2.16 Autobio Diagnostics
2.16.1 Autobio Diagnostics Details
2.16.2 Autobio Diagnostics Major Business
2.16.3 Autobio Diagnostics Antimicrobial Susceptibility Testing Products Product and Solutions
2.16.4 Autobio Diagnostics Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Autobio Diagnostics Recent Developments and Future Plans
2.17 Mast Group
2.17.1 Mast Group Details
2.17.2 Mast Group Major Business
2.17.3 Mast Group Antimicrobial Susceptibility Testing Products Product and Solutions
2.17.4 Mast Group Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Mast Group Recent Developments and Future Plans
2.18 Erba Lachema
2.18.1 Erba Lachema Details
2.18.2 Erba Lachema Major Business
2.18.3 Erba Lachema Antimicrobial Susceptibility Testing Products Product and Solutions
2.18.4 Erba Lachema Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Erba Lachema Recent Developments and Future Plans
2.19 Alifax
2.19.1 Alifax Details
2.19.2 Alifax Major Business
2.19.3 Alifax Antimicrobial Susceptibility Testing Products Product and Solutions
2.19.4 Alifax Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Alifax Recent Developments and Future Plans
2.20 ZHUHAI DL BIOTECH
2.20.1 ZHUHAI DL BIOTECH Details
2.20.2 ZHUHAI DL BIOTECH Major Business
2.20.3 ZHUHAI DL BIOTECH Antimicrobial Susceptibility Testing Products Product and Solutions
2.20.4 ZHUHAI DL BIOTECH Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 ZHUHAI DL BIOTECH Recent Developments and Future Plans
2.21 Kyokuto Pharmaceutical Industrial
2.21.1 Kyokuto Pharmaceutical Industrial Details
2.21.2 Kyokuto Pharmaceutical Industrial Major Business
2.21.3 Kyokuto Pharmaceutical Industrial Antimicrobial Susceptibility Testing Products Product and Solutions
2.21.4 Kyokuto Pharmaceutical Industrial Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Kyokuto Pharmaceutical Industrial Recent Developments and Future Plans
2.22 Condalab
2.22.1 Condalab Details
2.22.2 Condalab Major Business
2.22.3 Condalab Antimicrobial Susceptibility Testing Products Product and Solutions
2.22.4 Condalab Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 Condalab Recent Developments and Future Plans
2.23 Titan Biotech
2.23.1 Titan Biotech Details
2.23.2 Titan Biotech Major Business
2.23.3 Titan Biotech Antimicrobial Susceptibility Testing Products Product and Solutions
2.23.4 Titan Biotech Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Titan Biotech Recent Developments and Future Plans
2.24 Guangdong Huankai Microbial
2.24.1 Guangdong Huankai Microbial Details
2.24.2 Guangdong Huankai Microbial Major Business
2.24.3 Guangdong Huankai Microbial Antimicrobial Susceptibility Testing Products Product and Solutions
2.24.4 Guangdong Huankai Microbial Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Guangdong Huankai Microbial Recent Developments and Future Plans
2.25 Bioanalyse
2.25.1 Bioanalyse Details
2.25.2 Bioanalyse Major Business
2.25.3 Bioanalyse Antimicrobial Susceptibility Testing Products Product and Solutions
2.25.4 Bioanalyse Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 Bioanalyse Recent Developments and Future Plans
2.26 Synbiosis
2.26.1 Synbiosis Details
2.26.2 Synbiosis Major Business
2.26.3 Synbiosis Antimicrobial Susceptibility Testing Products Product and Solutions
2.26.4 Synbiosis Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 Synbiosis Recent Developments and Future Plans
2.27 Biolife Italiana
2.27.1 Biolife Italiana Details
2.27.2 Biolife Italiana Major Business
2.27.3 Biolife Italiana Antimicrobial Susceptibility Testing Products Product and Solutions
2.27.4 Biolife Italiana Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.27.5 Biolife Italiana Recent Developments and Future Plans
2.28 Gradientech
2.28.1 Gradientech Details
2.28.2 Gradientech Major Business
2.28.3 Gradientech Antimicrobial Susceptibility Testing Products Product and Solutions
2.28.4 Gradientech Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.28.5 Gradientech Recent Developments and Future Plans
2.29 Selux Diagnostics
2.29.1 Selux Diagnostics Details
2.29.2 Selux Diagnostics Major Business
2.29.3 Selux Diagnostics Antimicrobial Susceptibility Testing Products Product and Solutions
2.29.4 Selux Diagnostics Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.29.5 Selux Diagnostics Recent Developments and Future Plans
2.30 iFAST Diagnostics
2.30.1 iFAST Diagnostics Details
2.30.2 iFAST Diagnostics Major Business
2.30.3 iFAST Diagnostics Antimicrobial Susceptibility Testing Products Product and Solutions
2.30.4 iFAST Diagnostics Antimicrobial Susceptibility Testing Products Revenue, Gross Margin and Market Share (2021-2026)
2.30.5 iFAST Diagnostics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Antimicrobial Susceptibility Testing Products Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Antimicrobial Susceptibility Testing Products by Company Revenue
3.2.2 Top 3 Antimicrobial Susceptibility Testing Products Players Market Share in 2025
3.2.3 Top 6 Antimicrobial Susceptibility Testing Products Players Market Share in 2025
3.3 Antimicrobial Susceptibility Testing Products Market: Overall Company Footprint Analysis
3.3.1 Antimicrobial Susceptibility Testing Products Market: Region Footprint
3.3.2 Antimicrobial Susceptibility Testing Products Market: Company Product Type Footprint
3.3.3 Antimicrobial Susceptibility Testing Products Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Antimicrobial Susceptibility Testing Products Consumption Value and Market Share by Type (2021-2026)
4.2 Global Antimicrobial Susceptibility Testing Products Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Application (2021-2026)
5.2 Global Antimicrobial Susceptibility Testing Products Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Antimicrobial Susceptibility Testing Products Consumption Value by Type (2021-2032)
6.2 North America Antimicrobial Susceptibility Testing Products Market Size by Application (2021-2032)
6.3 North America Antimicrobial Susceptibility Testing Products Market Size by Country
6.3.1 North America Antimicrobial Susceptibility Testing Products Consumption Value by Country (2021-2032)
6.3.2 United States Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
6.3.3 Canada Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
6.3.4 Mexico Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Antimicrobial Susceptibility Testing Products Consumption Value by Type (2021-2032)
7.2 Europe Antimicrobial Susceptibility Testing Products Consumption Value by Application (2021-2032)
7.3 Europe Antimicrobial Susceptibility Testing Products Market Size by Country
7.3.1 Europe Antimicrobial Susceptibility Testing Products Consumption Value by Country (2021-2032)
7.3.2 Germany Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
7.3.3 France Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
7.3.5 Russia Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
7.3.6 Italy Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Antimicrobial Susceptibility Testing Products Market Size by Region
8.3.1 Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value by Region (2021-2032)
8.3.2 China Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
8.3.3 Japan Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
8.3.4 South Korea Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
8.3.5 India Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
8.3.7 Australia Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Antimicrobial Susceptibility Testing Products Consumption Value by Type (2021-2032)
9.2 South America Antimicrobial Susceptibility Testing Products Consumption Value by Application (2021-2032)
9.3 South America Antimicrobial Susceptibility Testing Products Market Size by Country
9.3.1 South America Antimicrobial Susceptibility Testing Products Consumption Value by Country (2021-2032)
9.3.2 Brazil Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
9.3.3 Argentina Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Antimicrobial Susceptibility Testing Products Market Size by Country
10.3.1 Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value by Country (2021-2032)
10.3.2 Turkey Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
10.3.4 UAE Antimicrobial Susceptibility Testing Products Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Antimicrobial Susceptibility Testing Products Market Drivers
11.2 Antimicrobial Susceptibility Testing Products Market Restraints
11.3 Antimicrobial Susceptibility Testing Products Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Antimicrobial Susceptibility Testing Products Industry Chain
12.2 Antimicrobial Susceptibility Testing Products Upstream Analysis
12.3 Antimicrobial Susceptibility Testing Products Midstream Analysis
12.4 Antimicrobial Susceptibility Testing Products Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Antimicrobial Susceptibility Testing Products Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Antimicrobial Susceptibility Testing Products Consumption Value by Core Testing Principle, (USD Million), 2021 & 2025 & 2032
Table 3. Global Antimicrobial Susceptibility Testing Products Consumption Value by Automation Level, (USD Million), 2021 & 2025 & 2032
Table 4. Global Antimicrobial Susceptibility Testing Products Consumption Value by Delivery Format, (USD Million), 2021 & 2025 & 2032
Table 5. Global Antimicrobial Susceptibility Testing Products Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Global Antimicrobial Susceptibility Testing Products Consumption Value by Region (2021-2026) & (USD Million)
Table 7. Global Antimicrobial Susceptibility Testing Products Consumption Value by Region (2027-2032) & (USD Million)
Table 8. Danaher Company Information, Head Office, and Major Competitors
Table 9. Danaher Major Business
Table 10. Danaher Antimicrobial Susceptibility Testing Products Product and Solutions
Table 11. Danaher Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Danaher Recent Developments and Future Plans
Table 13. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 14. Thermo Fisher Scientific Major Business
Table 15. Thermo Fisher Scientific Antimicrobial Susceptibility Testing Products Product and Solutions
Table 16. Thermo Fisher Scientific Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Thermo Fisher Scientific Recent Developments and Future Plans
Table 18. BD Company Information, Head Office, and Major Competitors
Table 19. BD Major Business
Table 20. BD Antimicrobial Susceptibility Testing Products Product and Solutions
Table 21. BD Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. bioM?rieux Company Information, Head Office, and Major Competitors
Table 23. bioM?rieux Major Business
Table 24. bioM?rieux Antimicrobial Susceptibility Testing Products Product and Solutions
Table 25. bioM?rieux Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 26. bioM?rieux Recent Developments and Future Plans
Table 27. Merck Company Information, Head Office, and Major Competitors
Table 28. Merck Major Business
Table 29. Merck Antimicrobial Susceptibility Testing Products Product and Solutions
Table 30. Merck Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 31. Merck Recent Developments and Future Plans
Table 32. Sysmex Company Information, Head Office, and Major Competitors
Table 33. Sysmex Major Business
Table 34. Sysmex Antimicrobial Susceptibility Testing Products Product and Solutions
Table 35. Sysmex Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 36. Sysmex Recent Developments and Future Plans
Table 37. Mindray Company Information, Head Office, and Major Competitors
Table 38. Mindray Major Business
Table 39. Mindray Antimicrobial Susceptibility Testing Products Product and Solutions
Table 40. Mindray Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 41. Mindray Recent Developments and Future Plans
Table 42. Bio-Rad Company Information, Head Office, and Major Competitors
Table 43. Bio-Rad Major Business
Table 44. Bio-Rad Antimicrobial Susceptibility Testing Products Product and Solutions
Table 45. Bio-Rad Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 46. Bio-Rad Recent Developments and Future Plans
Table 47. Bruker Company Information, Head Office, and Major Competitors
Table 48. Bruker Major Business
Table 49. Bruker Antimicrobial Susceptibility Testing Products Product and Solutions
Table 50. Bruker Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 51. Bruker Recent Developments and Future Plans
Table 52. Eiken Chemical Company Information, Head Office, and Major Competitors
Table 53. Eiken Chemical Major Business
Table 54. Eiken Chemical Antimicrobial Susceptibility Testing Products Product and Solutions
Table 55. Eiken Chemical Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 56. Eiken Chemical Recent Developments and Future Plans
Table 57. Copan Diagnostics Company Information, Head Office, and Major Competitors
Table 58. Copan Diagnostics Major Business
Table 59. Copan Diagnostics Antimicrobial Susceptibility Testing Products Product and Solutions
Table 60. Copan Diagnostics Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 61. Copan Diagnostics Recent Developments and Future Plans
Table 62. Q-linea Company Information, Head Office, and Major Competitors
Table 63. Q-linea Major Business
Table 64. Q-linea Antimicrobial Susceptibility Testing Products Product and Solutions
Table 65. Q-linea Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 66. Q-linea Recent Developments and Future Plans
Table 67. QuantaMatrix Company Information, Head Office, and Major Competitors
Table 68. QuantaMatrix Major Business
Table 69. QuantaMatrix Antimicrobial Susceptibility Testing Products Product and Solutions
Table 70. QuantaMatrix Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. QuantaMatrix Recent Developments and Future Plans
Table 72. HiMedia Laboratories Company Information, Head Office, and Major Competitors
Table 73. HiMedia Laboratories Major Business
Table 74. HiMedia Laboratories Antimicrobial Susceptibility Testing Products Product and Solutions
Table 75. HiMedia Laboratories Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 76. HiMedia Laboratories Recent Developments and Future Plans
Table 77. Liofilchem Company Information, Head Office, and Major Competitors
Table 78. Liofilchem Major Business
Table 79. Liofilchem Antimicrobial Susceptibility Testing Products Product and Solutions
Table 80. Liofilchem Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 81. Liofilchem Recent Developments and Future Plans
Table 82. Autobio Diagnostics Company Information, Head Office, and Major Competitors
Table 83. Autobio Diagnostics Major Business
Table 84. Autobio Diagnostics Antimicrobial Susceptibility Testing Products Product and Solutions
Table 85. Autobio Diagnostics Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Autobio Diagnostics Recent Developments and Future Plans
Table 87. Mast Group Company Information, Head Office, and Major Competitors
Table 88. Mast Group Major Business
Table 89. Mast Group Antimicrobial Susceptibility Testing Products Product and Solutions
Table 90. Mast Group Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Mast Group Recent Developments and Future Plans
Table 92. Erba Lachema Company Information, Head Office, and Major Competitors
Table 93. Erba Lachema Major Business
Table 94. Erba Lachema Antimicrobial Susceptibility Testing Products Product and Solutions
Table 95. Erba Lachema Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Erba Lachema Recent Developments and Future Plans
Table 97. Alifax Company Information, Head Office, and Major Competitors
Table 98. Alifax Major Business
Table 99. Alifax Antimicrobial Susceptibility Testing Products Product and Solutions
Table 100. Alifax Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Alifax Recent Developments and Future Plans
Table 102. ZHUHAI DL BIOTECH Company Information, Head Office, and Major Competitors
Table 103. ZHUHAI DL BIOTECH Major Business
Table 104. ZHUHAI DL BIOTECH Antimicrobial Susceptibility Testing Products Product and Solutions
Table 105. ZHUHAI DL BIOTECH Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 106. ZHUHAI DL BIOTECH Recent Developments and Future Plans
Table 107. Kyokuto Pharmaceutical Industrial Company Information, Head Office, and Major Competitors
Table 108. Kyokuto Pharmaceutical Industrial Major Business
Table 109. Kyokuto Pharmaceutical Industrial Antimicrobial Susceptibility Testing Products Product and Solutions
Table 110. Kyokuto Pharmaceutical Industrial Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 111. Kyokuto Pharmaceutical Industrial Recent Developments and Future Plans
Table 112. Condalab Company Information, Head Office, and Major Competitors
Table 113. Condalab Major Business
Table 114. Condalab Antimicrobial Susceptibility Testing Products Product and Solutions
Table 115. Condalab Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. Condalab Recent Developments and Future Plans
Table 117. Titan Biotech Company Information, Head Office, and Major Competitors
Table 118. Titan Biotech Major Business
Table 119. Titan Biotech Antimicrobial Susceptibility Testing Products Product and Solutions
Table 120. Titan Biotech Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Titan Biotech Recent Developments and Future Plans
Table 122. Guangdong Huankai Microbial Company Information, Head Office, and Major Competitors
Table 123. Guangdong Huankai Microbial Major Business
Table 124. Guangdong Huankai Microbial Antimicrobial Susceptibility Testing Products Product and Solutions
Table 125. Guangdong Huankai Microbial Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. Guangdong Huankai Microbial Recent Developments and Future Plans
Table 127. Bioanalyse Company Information, Head Office, and Major Competitors
Table 128. Bioanalyse Major Business
Table 129. Bioanalyse Antimicrobial Susceptibility Testing Products Product and Solutions
Table 130. Bioanalyse Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. Bioanalyse Recent Developments and Future Plans
Table 132. Synbiosis Company Information, Head Office, and Major Competitors
Table 133. Synbiosis Major Business
Table 134. Synbiosis Antimicrobial Susceptibility Testing Products Product and Solutions
Table 135. Synbiosis Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 136. Synbiosis Recent Developments and Future Plans
Table 137. Biolife Italiana Company Information, Head Office, and Major Competitors
Table 138. Biolife Italiana Major Business
Table 139. Biolife Italiana Antimicrobial Susceptibility Testing Products Product and Solutions
Table 140. Biolife Italiana Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 141. Biolife Italiana Recent Developments and Future Plans
Table 142. Gradientech Company Information, Head Office, and Major Competitors
Table 143. Gradientech Major Business
Table 144. Gradientech Antimicrobial Susceptibility Testing Products Product and Solutions
Table 145. Gradientech Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 146. Gradientech Recent Developments and Future Plans
Table 147. Selux Diagnostics Company Information, Head Office, and Major Competitors
Table 148. Selux Diagnostics Major Business
Table 149. Selux Diagnostics Antimicrobial Susceptibility Testing Products Product and Solutions
Table 150. Selux Diagnostics Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Selux Diagnostics Recent Developments and Future Plans
Table 152. iFAST Diagnostics Company Information, Head Office, and Major Competitors
Table 153. iFAST Diagnostics Major Business
Table 154. iFAST Diagnostics Antimicrobial Susceptibility Testing Products Product and Solutions
Table 155. iFAST Diagnostics Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 156. iFAST Diagnostics Recent Developments and Future Plans
Table 157. Global Antimicrobial Susceptibility Testing Products Revenue (USD Million) by Players (2021-2026)
Table 158. Global Antimicrobial Susceptibility Testing Products Revenue Share by Players (2021-2026)
Table 159. Breakdown of Antimicrobial Susceptibility Testing Products by Company Type (Tier 1, Tier 2, and Tier 3)
Table 160. Market Position of Players in Antimicrobial Susceptibility Testing Products, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 161. Head Office of Key Antimicrobial Susceptibility Testing Products Players
Table 162. Antimicrobial Susceptibility Testing Products Market: Company Product Type Footprint
Table 163. Antimicrobial Susceptibility Testing Products Market: Company Product Application Footprint
Table 164. Antimicrobial Susceptibility Testing Products New Market Entrants and Barriers to Market Entry
Table 165. Antimicrobial Susceptibility Testing Products Mergers, Acquisition, Agreements, and Collaborations
Table 166. Global Antimicrobial Susceptibility Testing Products Consumption Value (USD Million) by Type (2021-2026)
Table 167. Global Antimicrobial Susceptibility Testing Products Consumption Value Share by Type (2021-2026)
Table 168. Global Antimicrobial Susceptibility Testing Products Consumption Value Forecast by Type (2027-2032)
Table 169. Global Antimicrobial Susceptibility Testing Products Consumption Value by Application (2021-2026)
Table 170. Global Antimicrobial Susceptibility Testing Products Consumption Value Forecast by Application (2027-2032)
Table 171. North America Antimicrobial Susceptibility Testing Products Consumption Value by Type (2021-2026) & (USD Million)
Table 172. North America Antimicrobial Susceptibility Testing Products Consumption Value by Type (2027-2032) & (USD Million)
Table 173. North America Antimicrobial Susceptibility Testing Products Consumption Value by Application (2021-2026) & (USD Million)
Table 174. North America Antimicrobial Susceptibility Testing Products Consumption Value by Application (2027-2032) & (USD Million)
Table 175. North America Antimicrobial Susceptibility Testing Products Consumption Value by Country (2021-2026) & (USD Million)
Table 176. North America Antimicrobial Susceptibility Testing Products Consumption Value by Country (2027-2032) & (USD Million)
Table 177. Europe Antimicrobial Susceptibility Testing Products Consumption Value by Type (2021-2026) & (USD Million)
Table 178. Europe Antimicrobial Susceptibility Testing Products Consumption Value by Type (2027-2032) & (USD Million)
Table 179. Europe Antimicrobial Susceptibility Testing Products Consumption Value by Application (2021-2026) & (USD Million)
Table 180. Europe Antimicrobial Susceptibility Testing Products Consumption Value by Application (2027-2032) & (USD Million)
Table 181. Europe Antimicrobial Susceptibility Testing Products Consumption Value by Country (2021-2026) & (USD Million)
Table 182. Europe Antimicrobial Susceptibility Testing Products Consumption Value by Country (2027-2032) & (USD Million)
Table 183. Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value by Type (2021-2026) & (USD Million)
Table 184. Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value by Type (2027-2032) & (USD Million)
Table 185. Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value by Application (2021-2026) & (USD Million)
Table 186. Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value by Application (2027-2032) & (USD Million)
Table 187. Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value by Region (2021-2026) & (USD Million)
Table 188. Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value by Region (2027-2032) & (USD Million)
Table 189. South America Antimicrobial Susceptibility Testing Products Consumption Value by Type (2021-2026) & (USD Million)
Table 190. South America Antimicrobial Susceptibility Testing Products Consumption Value by Type (2027-2032) & (USD Million)
Table 191. South America Antimicrobial Susceptibility Testing Products Consumption Value by Application (2021-2026) & (USD Million)
Table 192. South America Antimicrobial Susceptibility Testing Products Consumption Value by Application (2027-2032) & (USD Million)
Table 193. South America Antimicrobial Susceptibility Testing Products Consumption Value by Country (2021-2026) & (USD Million)
Table 194. South America Antimicrobial Susceptibility Testing Products Consumption Value by Country (2027-2032) & (USD Million)
Table 195. Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value by Type (2021-2026) & (USD Million)
Table 196. Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value by Type (2027-2032) & (USD Million)
Table 197. Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value by Application (2021-2026) & (USD Million)
Table 198. Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value by Application (2027-2032) & (USD Million)
Table 199. Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value by Country (2021-2026) & (USD Million)
Table 200. Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value by Country (2027-2032) & (USD Million)
Table 201. Global Key Players of Antimicrobial Susceptibility Testing Products Upstream (Raw Materials)
Table 202. Global Antimicrobial Susceptibility Testing Products Typical Customers
Table 1. Global Antimicrobial Susceptibility Testing Products Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Antimicrobial Susceptibility Testing Products Consumption Value by Core Testing Principle, (USD Million), 2021 & 2025 & 2032
Table 3. Global Antimicrobial Susceptibility Testing Products Consumption Value by Automation Level, (USD Million), 2021 & 2025 & 2032
Table 4. Global Antimicrobial Susceptibility Testing Products Consumption Value by Delivery Format, (USD Million), 2021 & 2025 & 2032
Table 5. Global Antimicrobial Susceptibility Testing Products Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Global Antimicrobial Susceptibility Testing Products Consumption Value by Region (2021-2026) & (USD Million)
Table 7. Global Antimicrobial Susceptibility Testing Products Consumption Value by Region (2027-2032) & (USD Million)
Table 8. Danaher Company Information, Head Office, and Major Competitors
Table 9. Danaher Major Business
Table 10. Danaher Antimicrobial Susceptibility Testing Products Product and Solutions
Table 11. Danaher Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Danaher Recent Developments and Future Plans
Table 13. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 14. Thermo Fisher Scientific Major Business
Table 15. Thermo Fisher Scientific Antimicrobial Susceptibility Testing Products Product and Solutions
Table 16. Thermo Fisher Scientific Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Thermo Fisher Scientific Recent Developments and Future Plans
Table 18. BD Company Information, Head Office, and Major Competitors
Table 19. BD Major Business
Table 20. BD Antimicrobial Susceptibility Testing Products Product and Solutions
Table 21. BD Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. bioM?rieux Company Information, Head Office, and Major Competitors
Table 23. bioM?rieux Major Business
Table 24. bioM?rieux Antimicrobial Susceptibility Testing Products Product and Solutions
Table 25. bioM?rieux Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 26. bioM?rieux Recent Developments and Future Plans
Table 27. Merck Company Information, Head Office, and Major Competitors
Table 28. Merck Major Business
Table 29. Merck Antimicrobial Susceptibility Testing Products Product and Solutions
Table 30. Merck Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 31. Merck Recent Developments and Future Plans
Table 32. Sysmex Company Information, Head Office, and Major Competitors
Table 33. Sysmex Major Business
Table 34. Sysmex Antimicrobial Susceptibility Testing Products Product and Solutions
Table 35. Sysmex Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 36. Sysmex Recent Developments and Future Plans
Table 37. Mindray Company Information, Head Office, and Major Competitors
Table 38. Mindray Major Business
Table 39. Mindray Antimicrobial Susceptibility Testing Products Product and Solutions
Table 40. Mindray Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 41. Mindray Recent Developments and Future Plans
Table 42. Bio-Rad Company Information, Head Office, and Major Competitors
Table 43. Bio-Rad Major Business
Table 44. Bio-Rad Antimicrobial Susceptibility Testing Products Product and Solutions
Table 45. Bio-Rad Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 46. Bio-Rad Recent Developments and Future Plans
Table 47. Bruker Company Information, Head Office, and Major Competitors
Table 48. Bruker Major Business
Table 49. Bruker Antimicrobial Susceptibility Testing Products Product and Solutions
Table 50. Bruker Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 51. Bruker Recent Developments and Future Plans
Table 52. Eiken Chemical Company Information, Head Office, and Major Competitors
Table 53. Eiken Chemical Major Business
Table 54. Eiken Chemical Antimicrobial Susceptibility Testing Products Product and Solutions
Table 55. Eiken Chemical Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 56. Eiken Chemical Recent Developments and Future Plans
Table 57. Copan Diagnostics Company Information, Head Office, and Major Competitors
Table 58. Copan Diagnostics Major Business
Table 59. Copan Diagnostics Antimicrobial Susceptibility Testing Products Product and Solutions
Table 60. Copan Diagnostics Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 61. Copan Diagnostics Recent Developments and Future Plans
Table 62. Q-linea Company Information, Head Office, and Major Competitors
Table 63. Q-linea Major Business
Table 64. Q-linea Antimicrobial Susceptibility Testing Products Product and Solutions
Table 65. Q-linea Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 66. Q-linea Recent Developments and Future Plans
Table 67. QuantaMatrix Company Information, Head Office, and Major Competitors
Table 68. QuantaMatrix Major Business
Table 69. QuantaMatrix Antimicrobial Susceptibility Testing Products Product and Solutions
Table 70. QuantaMatrix Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. QuantaMatrix Recent Developments and Future Plans
Table 72. HiMedia Laboratories Company Information, Head Office, and Major Competitors
Table 73. HiMedia Laboratories Major Business
Table 74. HiMedia Laboratories Antimicrobial Susceptibility Testing Products Product and Solutions
Table 75. HiMedia Laboratories Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 76. HiMedia Laboratories Recent Developments and Future Plans
Table 77. Liofilchem Company Information, Head Office, and Major Competitors
Table 78. Liofilchem Major Business
Table 79. Liofilchem Antimicrobial Susceptibility Testing Products Product and Solutions
Table 80. Liofilchem Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 81. Liofilchem Recent Developments and Future Plans
Table 82. Autobio Diagnostics Company Information, Head Office, and Major Competitors
Table 83. Autobio Diagnostics Major Business
Table 84. Autobio Diagnostics Antimicrobial Susceptibility Testing Products Product and Solutions
Table 85. Autobio Diagnostics Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Autobio Diagnostics Recent Developments and Future Plans
Table 87. Mast Group Company Information, Head Office, and Major Competitors
Table 88. Mast Group Major Business
Table 89. Mast Group Antimicrobial Susceptibility Testing Products Product and Solutions
Table 90. Mast Group Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Mast Group Recent Developments and Future Plans
Table 92. Erba Lachema Company Information, Head Office, and Major Competitors
Table 93. Erba Lachema Major Business
Table 94. Erba Lachema Antimicrobial Susceptibility Testing Products Product and Solutions
Table 95. Erba Lachema Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Erba Lachema Recent Developments and Future Plans
Table 97. Alifax Company Information, Head Office, and Major Competitors
Table 98. Alifax Major Business
Table 99. Alifax Antimicrobial Susceptibility Testing Products Product and Solutions
Table 100. Alifax Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Alifax Recent Developments and Future Plans
Table 102. ZHUHAI DL BIOTECH Company Information, Head Office, and Major Competitors
Table 103. ZHUHAI DL BIOTECH Major Business
Table 104. ZHUHAI DL BIOTECH Antimicrobial Susceptibility Testing Products Product and Solutions
Table 105. ZHUHAI DL BIOTECH Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 106. ZHUHAI DL BIOTECH Recent Developments and Future Plans
Table 107. Kyokuto Pharmaceutical Industrial Company Information, Head Office, and Major Competitors
Table 108. Kyokuto Pharmaceutical Industrial Major Business
Table 109. Kyokuto Pharmaceutical Industrial Antimicrobial Susceptibility Testing Products Product and Solutions
Table 110. Kyokuto Pharmaceutical Industrial Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 111. Kyokuto Pharmaceutical Industrial Recent Developments and Future Plans
Table 112. Condalab Company Information, Head Office, and Major Competitors
Table 113. Condalab Major Business
Table 114. Condalab Antimicrobial Susceptibility Testing Products Product and Solutions
Table 115. Condalab Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. Condalab Recent Developments and Future Plans
Table 117. Titan Biotech Company Information, Head Office, and Major Competitors
Table 118. Titan Biotech Major Business
Table 119. Titan Biotech Antimicrobial Susceptibility Testing Products Product and Solutions
Table 120. Titan Biotech Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Titan Biotech Recent Developments and Future Plans
Table 122. Guangdong Huankai Microbial Company Information, Head Office, and Major Competitors
Table 123. Guangdong Huankai Microbial Major Business
Table 124. Guangdong Huankai Microbial Antimicrobial Susceptibility Testing Products Product and Solutions
Table 125. Guangdong Huankai Microbial Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. Guangdong Huankai Microbial Recent Developments and Future Plans
Table 127. Bioanalyse Company Information, Head Office, and Major Competitors
Table 128. Bioanalyse Major Business
Table 129. Bioanalyse Antimicrobial Susceptibility Testing Products Product and Solutions
Table 130. Bioanalyse Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. Bioanalyse Recent Developments and Future Plans
Table 132. Synbiosis Company Information, Head Office, and Major Competitors
Table 133. Synbiosis Major Business
Table 134. Synbiosis Antimicrobial Susceptibility Testing Products Product and Solutions
Table 135. Synbiosis Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 136. Synbiosis Recent Developments and Future Plans
Table 137. Biolife Italiana Company Information, Head Office, and Major Competitors
Table 138. Biolife Italiana Major Business
Table 139. Biolife Italiana Antimicrobial Susceptibility Testing Products Product and Solutions
Table 140. Biolife Italiana Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 141. Biolife Italiana Recent Developments and Future Plans
Table 142. Gradientech Company Information, Head Office, and Major Competitors
Table 143. Gradientech Major Business
Table 144. Gradientech Antimicrobial Susceptibility Testing Products Product and Solutions
Table 145. Gradientech Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 146. Gradientech Recent Developments and Future Plans
Table 147. Selux Diagnostics Company Information, Head Office, and Major Competitors
Table 148. Selux Diagnostics Major Business
Table 149. Selux Diagnostics Antimicrobial Susceptibility Testing Products Product and Solutions
Table 150. Selux Diagnostics Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Selux Diagnostics Recent Developments and Future Plans
Table 152. iFAST Diagnostics Company Information, Head Office, and Major Competitors
Table 153. iFAST Diagnostics Major Business
Table 154. iFAST Diagnostics Antimicrobial Susceptibility Testing Products Product and Solutions
Table 155. iFAST Diagnostics Antimicrobial Susceptibility Testing Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 156. iFAST Diagnostics Recent Developments and Future Plans
Table 157. Global Antimicrobial Susceptibility Testing Products Revenue (USD Million) by Players (2021-2026)
Table 158. Global Antimicrobial Susceptibility Testing Products Revenue Share by Players (2021-2026)
Table 159. Breakdown of Antimicrobial Susceptibility Testing Products by Company Type (Tier 1, Tier 2, and Tier 3)
Table 160. Market Position of Players in Antimicrobial Susceptibility Testing Products, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 161. Head Office of Key Antimicrobial Susceptibility Testing Products Players
Table 162. Antimicrobial Susceptibility Testing Products Market: Company Product Type Footprint
Table 163. Antimicrobial Susceptibility Testing Products Market: Company Product Application Footprint
Table 164. Antimicrobial Susceptibility Testing Products New Market Entrants and Barriers to Market Entry
Table 165. Antimicrobial Susceptibility Testing Products Mergers, Acquisition, Agreements, and Collaborations
Table 166. Global Antimicrobial Susceptibility Testing Products Consumption Value (USD Million) by Type (2021-2026)
Table 167. Global Antimicrobial Susceptibility Testing Products Consumption Value Share by Type (2021-2026)
Table 168. Global Antimicrobial Susceptibility Testing Products Consumption Value Forecast by Type (2027-2032)
Table 169. Global Antimicrobial Susceptibility Testing Products Consumption Value by Application (2021-2026)
Table 170. Global Antimicrobial Susceptibility Testing Products Consumption Value Forecast by Application (2027-2032)
Table 171. North America Antimicrobial Susceptibility Testing Products Consumption Value by Type (2021-2026) & (USD Million)
Table 172. North America Antimicrobial Susceptibility Testing Products Consumption Value by Type (2027-2032) & (USD Million)
Table 173. North America Antimicrobial Susceptibility Testing Products Consumption Value by Application (2021-2026) & (USD Million)
Table 174. North America Antimicrobial Susceptibility Testing Products Consumption Value by Application (2027-2032) & (USD Million)
Table 175. North America Antimicrobial Susceptibility Testing Products Consumption Value by Country (2021-2026) & (USD Million)
Table 176. North America Antimicrobial Susceptibility Testing Products Consumption Value by Country (2027-2032) & (USD Million)
Table 177. Europe Antimicrobial Susceptibility Testing Products Consumption Value by Type (2021-2026) & (USD Million)
Table 178. Europe Antimicrobial Susceptibility Testing Products Consumption Value by Type (2027-2032) & (USD Million)
Table 179. Europe Antimicrobial Susceptibility Testing Products Consumption Value by Application (2021-2026) & (USD Million)
Table 180. Europe Antimicrobial Susceptibility Testing Products Consumption Value by Application (2027-2032) & (USD Million)
Table 181. Europe Antimicrobial Susceptibility Testing Products Consumption Value by Country (2021-2026) & (USD Million)
Table 182. Europe Antimicrobial Susceptibility Testing Products Consumption Value by Country (2027-2032) & (USD Million)
Table 183. Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value by Type (2021-2026) & (USD Million)
Table 184. Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value by Type (2027-2032) & (USD Million)
Table 185. Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value by Application (2021-2026) & (USD Million)
Table 186. Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value by Application (2027-2032) & (USD Million)
Table 187. Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value by Region (2021-2026) & (USD Million)
Table 188. Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value by Region (2027-2032) & (USD Million)
Table 189. South America Antimicrobial Susceptibility Testing Products Consumption Value by Type (2021-2026) & (USD Million)
Table 190. South America Antimicrobial Susceptibility Testing Products Consumption Value by Type (2027-2032) & (USD Million)
Table 191. South America Antimicrobial Susceptibility Testing Products Consumption Value by Application (2021-2026) & (USD Million)
Table 192. South America Antimicrobial Susceptibility Testing Products Consumption Value by Application (2027-2032) & (USD Million)
Table 193. South America Antimicrobial Susceptibility Testing Products Consumption Value by Country (2021-2026) & (USD Million)
Table 194. South America Antimicrobial Susceptibility Testing Products Consumption Value by Country (2027-2032) & (USD Million)
Table 195. Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value by Type (2021-2026) & (USD Million)
Table 196. Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value by Type (2027-2032) & (USD Million)
Table 197. Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value by Application (2021-2026) & (USD Million)
Table 198. Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value by Application (2027-2032) & (USD Million)
Table 199. Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value by Country (2021-2026) & (USD Million)
Table 200. Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value by Country (2027-2032) & (USD Million)
Table 201. Global Key Players of Antimicrobial Susceptibility Testing Products Upstream (Raw Materials)
Table 202. Global Antimicrobial Susceptibility Testing Products Typical Customers
LIST OF FIGURES
Figure 1. Antimicrobial Susceptibility Testing Products Picture
Figure 2. Global Antimicrobial Susceptibility Testing Products Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Type in 2025
Figure 4. AST Instruments and Systems
Figure 5. AST Test Consumables
Figure 6. AST Media and Reagents
Figure 7. AST Software and Data Tools
Figure 8. Others
Figure 9. Global Antimicrobial Susceptibility Testing Products Consumption Value by Core Testing Principle, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Core Testing Principle in 2025
Figure 11. Diffusion-based AST
Figure 12. Dilution-based AST
Figure 13. Growth Kinetics or Imaging-based AST
Figure 14. Microfluidic Rapid Phenotypic AST
Figure 15. Genotypic or Resistance-marker-guided Testing
Figure 16. Others
Figure 17. Global Antimicrobial Susceptibility Testing Products Consumption Value by Automation Level, (USD Million), 2021 & 2025 & 2032
Figure 18. Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Automation Level in 2025
Figure 19. Manual AST Products
Figure 20. Semi-automated AST Products
Figure 21. Fully Automated AST Products
Figure 22. Global Antimicrobial Susceptibility Testing Products Consumption Value by Delivery Format, (USD Million), 2021 & 2025 & 2032
Figure 23. Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Delivery Format in 2025
Figure 24. Capital Equipment
Figure 25. Single-use Test Consumables
Figure 26. Media and Supporting Supplies
Figure 27. Software, Database and Interpretation Tools
Figure 28. Others
Figure 29. Global Antimicrobial Susceptibility Testing Products Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 30. Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Application in 2025
Figure 31. Clinical Diagnostics Picture
Figure 32. Drug Discovery and Development Picture
Figure 33. Epidemiology Picture
Figure 34. Others Picture
Figure 35. Global Antimicrobial Susceptibility Testing Products Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 36. Global Antimicrobial Susceptibility Testing Products Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 37. Global Market Antimicrobial Susceptibility Testing Products Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 38. Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Region (2021-2032)
Figure 39. Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Region in 2025
Figure 40. North America Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 41. Europe Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 42. Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 43. South America Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 44. Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 45. Company Three Recent Developments and Future Plans
Figure 46. Global Antimicrobial Susceptibility Testing Products Revenue Share by Players in 2025
Figure 47. Antimicrobial Susceptibility Testing Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 48. Market Share of Antimicrobial Susceptibility Testing Products by Player Revenue in 2025
Figure 49. Top 3 Antimicrobial Susceptibility Testing Products Players Market Share in 2025
Figure 50. Top 6 Antimicrobial Susceptibility Testing Products Players Market Share in 2025
Figure 51. Global Antimicrobial Susceptibility Testing Products Consumption Value Share by Type (2021-2026)
Figure 52. Global Antimicrobial Susceptibility Testing Products Market Share Forecast by Type (2027-2032)
Figure 53. Global Antimicrobial Susceptibility Testing Products Consumption Value Share by Application (2021-2026)
Figure 54. Global Antimicrobial Susceptibility Testing Products Market Share Forecast by Application (2027-2032)
Figure 55. North America Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Type (2021-2032)
Figure 56. North America Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Application (2021-2032)
Figure 57. North America Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Country (2021-2032)
Figure 58. United States Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 59. Canada Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 60. Mexico Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 61. Europe Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Type (2021-2032)
Figure 62. Europe Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Application (2021-2032)
Figure 63. Europe Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Country (2021-2032)
Figure 64. Germany Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 65. France Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 66. United Kingdom Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 67. Russia Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 68. Italy Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 69. Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Type (2021-2032)
Figure 70. Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Application (2021-2032)
Figure 71. Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Region (2021-2032)
Figure 72. China Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 73. Japan Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 74. South Korea Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 75. India Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 76. Southeast Asia Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 77. Australia Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 78. South America Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Type (2021-2032)
Figure 79. South America Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Application (2021-2032)
Figure 80. South America Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Country (2021-2032)
Figure 81. Brazil Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 82. Argentina Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 83. Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Type (2021-2032)
Figure 84. Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Application (2021-2032)
Figure 85. Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Country (2021-2032)
Figure 86. Turkey Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 87. Saudi Arabia Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 88. UAE Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 89. Antimicrobial Susceptibility Testing Products Market Drivers
Figure 90. Antimicrobial Susceptibility Testing Products Market Restraints
Figure 91. Antimicrobial Susceptibility Testing Products Market Trends
Figure 92. Porters Five Forces Analysis
Figure 93. Antimicrobial Susceptibility Testing Products Industrial Chain
Figure 94. Methodology
Figure 95. Research Process and Data Source
Figure 1. Antimicrobial Susceptibility Testing Products Picture
Figure 2. Global Antimicrobial Susceptibility Testing Products Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Type in 2025
Figure 4. AST Instruments and Systems
Figure 5. AST Test Consumables
Figure 6. AST Media and Reagents
Figure 7. AST Software and Data Tools
Figure 8. Others
Figure 9. Global Antimicrobial Susceptibility Testing Products Consumption Value by Core Testing Principle, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Core Testing Principle in 2025
Figure 11. Diffusion-based AST
Figure 12. Dilution-based AST
Figure 13. Growth Kinetics or Imaging-based AST
Figure 14. Microfluidic Rapid Phenotypic AST
Figure 15. Genotypic or Resistance-marker-guided Testing
Figure 16. Others
Figure 17. Global Antimicrobial Susceptibility Testing Products Consumption Value by Automation Level, (USD Million), 2021 & 2025 & 2032
Figure 18. Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Automation Level in 2025
Figure 19. Manual AST Products
Figure 20. Semi-automated AST Products
Figure 21. Fully Automated AST Products
Figure 22. Global Antimicrobial Susceptibility Testing Products Consumption Value by Delivery Format, (USD Million), 2021 & 2025 & 2032
Figure 23. Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Delivery Format in 2025
Figure 24. Capital Equipment
Figure 25. Single-use Test Consumables
Figure 26. Media and Supporting Supplies
Figure 27. Software, Database and Interpretation Tools
Figure 28. Others
Figure 29. Global Antimicrobial Susceptibility Testing Products Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 30. Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Application in 2025
Figure 31. Clinical Diagnostics Picture
Figure 32. Drug Discovery and Development Picture
Figure 33. Epidemiology Picture
Figure 34. Others Picture
Figure 35. Global Antimicrobial Susceptibility Testing Products Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 36. Global Antimicrobial Susceptibility Testing Products Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 37. Global Market Antimicrobial Susceptibility Testing Products Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 38. Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Region (2021-2032)
Figure 39. Global Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Region in 2025
Figure 40. North America Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 41. Europe Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 42. Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 43. South America Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 44. Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 45. Company Three Recent Developments and Future Plans
Figure 46. Global Antimicrobial Susceptibility Testing Products Revenue Share by Players in 2025
Figure 47. Antimicrobial Susceptibility Testing Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 48. Market Share of Antimicrobial Susceptibility Testing Products by Player Revenue in 2025
Figure 49. Top 3 Antimicrobial Susceptibility Testing Products Players Market Share in 2025
Figure 50. Top 6 Antimicrobial Susceptibility Testing Products Players Market Share in 2025
Figure 51. Global Antimicrobial Susceptibility Testing Products Consumption Value Share by Type (2021-2026)
Figure 52. Global Antimicrobial Susceptibility Testing Products Market Share Forecast by Type (2027-2032)
Figure 53. Global Antimicrobial Susceptibility Testing Products Consumption Value Share by Application (2021-2026)
Figure 54. Global Antimicrobial Susceptibility Testing Products Market Share Forecast by Application (2027-2032)
Figure 55. North America Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Type (2021-2032)
Figure 56. North America Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Application (2021-2032)
Figure 57. North America Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Country (2021-2032)
Figure 58. United States Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 59. Canada Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 60. Mexico Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 61. Europe Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Type (2021-2032)
Figure 62. Europe Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Application (2021-2032)
Figure 63. Europe Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Country (2021-2032)
Figure 64. Germany Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 65. France Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 66. United Kingdom Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 67. Russia Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 68. Italy Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 69. Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Type (2021-2032)
Figure 70. Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Application (2021-2032)
Figure 71. Asia-Pacific Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Region (2021-2032)
Figure 72. China Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 73. Japan Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 74. South Korea Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 75. India Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 76. Southeast Asia Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 77. Australia Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 78. South America Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Type (2021-2032)
Figure 79. South America Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Application (2021-2032)
Figure 80. South America Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Country (2021-2032)
Figure 81. Brazil Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 82. Argentina Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 83. Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Type (2021-2032)
Figure 84. Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Application (2021-2032)
Figure 85. Middle East & Africa Antimicrobial Susceptibility Testing Products Consumption Value Market Share by Country (2021-2032)
Figure 86. Turkey Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 87. Saudi Arabia Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 88. UAE Antimicrobial Susceptibility Testing Products Consumption Value (2021-2032) & (USD Million)
Figure 89. Antimicrobial Susceptibility Testing Products Market Drivers
Figure 90. Antimicrobial Susceptibility Testing Products Market Restraints
Figure 91. Antimicrobial Susceptibility Testing Products Market Trends
Figure 92. Porters Five Forces Analysis
Figure 93. Antimicrobial Susceptibility Testing Products Industrial Chain
Figure 94. Methodology
Figure 95. Research Process and Data Source
